CompletedNot applicableNCT00004695
Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency
Studying OBSOLETE: Common variable immunodeficiency due to TNFR deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Principal Investigator
- Charlotte Cunningham-RundlesIcahn School of Medicine at Mount Sinai
- Intervention
- PEG-interleukin-2(drug)
- Enrollment
- 48 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 1997 – 2000
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004695 on ClinicalTrials.govOther trials for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT05193552Usage of Spirometry in Managing IgG Therapy in CVID with Airway DiseaseUniversity of Alabama at Birmingham
- ENROLLING BY INVITATIONPHASE2NCT05593588Senolytics Treatment of Interstitial Lung Disease in Common Variable ImmunodeficiencyAvni Joshi
- RECRUITINGPHASE2NCT02579967Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesNational Cancer Institute (NCI)
See all trials for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency →